These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10030770)

  • 1. Does the addition of pindolol accelerate or enhance the response to selective serotonin reuptake inhibitor antidepressants?
    Puzantian T; Kawase K
    Pharmacotherapy; 1999 Feb; 19(2):205-12. PubMed ID: 10030770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA; Nguyen HQ
    Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
    Blier P; Bergeron R; de Montigny C
    Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test.
    Bourin M; Redrobe JP; Baker GB
    Psychopharmacology (Berl); 1998 Apr; 136(3):226-34. PubMed ID: 9566807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?
    Cremers TI; Wiersma LJ; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
    Biol Psychiatry; 2001 Jul; 50(1):13-21. PubMed ID: 11457419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
    Moser PC; Sanger DJ
    Eur J Pharmacol; 1999 May; 372(2):127-34. PubMed ID: 10395092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
    Béïque JC; Blier P; de Montigny C; Debonnel G
    Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical effects of antidepressant augmentation.
    Howland RH
    Arch Gen Psychiatry; 1995 Feb; 52(2):156. PubMed ID: 7848052
    [No Abstract]   [Full Text] [Related]  

  • 10. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
    Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors.
    Perez M; Pauwels PJ; Pallard-Sigogneau I; Fourrier C; Chopin P; Palmier C; Colovray V; Halazy S
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3423-8. PubMed ID: 9873746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635.
    Fornal CA; Martin FJ; Metzler CW; Jacobs BL
    J Pharmacol Exp Ther; 1999 Oct; 291(1):220-8. PubMed ID: 10490908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of pindolol to potentiate antidepressant medication.
    Blier P; Bergeron R
    J Clin Psychiatry; 1998; 59 Suppl 5():16-23; discussion 24-5. PubMed ID: 9635544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency?
    Kinney GG; Taber MT; Gribkoff VK
    Mol Neurobiol; 2000 Jun; 21(3):137-52. PubMed ID: 11379796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interest of the use of pindolol in the treatment of depression: review].
    Brousse G; Schmitt A; Chereau I; Eschalier A; Dubray C; Llorca PM
    Encephale; 2003; 29(4 Pt 1):338-50. PubMed ID: 14615704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats.
    Nguyen KQ; Tohyama Y; Watanabe A; Hasegawa S; Skelin I; Diksic M
    Neurochem Int; 2009; 54(3-4):161-71. PubMed ID: 19073228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats.
    Wada Y; Hirao N; Shiraishi J; Nakamura M; Koshino Y
    Neurosci Lett; 1999 May; 267(1):61-4. PubMed ID: 10400249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction studies of 5-HT1A receptor antagonists and selective 5-HT reuptake inhibitors in isolated aggressive mice.
    Sànchez C
    Eur J Pharmacol; 1997 Sep; 334(2-3):127-32. PubMed ID: 9369340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of (+/-)-pindolol on the central 5-HT1A receptor by the use of in vivo microdialysis and hippocampal slice preparations].
    Tsuji K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Jun; 22(3):85-95. PubMed ID: 12166089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.
    Redrobe JP; Bourin M; Colombel MC; Baker GB
    J Psychopharmacol; 1998; 12(4):348-55. PubMed ID: 10065908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.